Human glioma-initiating cells show a distinct immature phenotype resembling but not identical to NG2 glia

Journal of Neuropathology and Experimental Neurology

Volumn 72, Issue 4, 2013, Pages 307-324

  Barrantes Freer, Alonso ^a,b   Kim, Ella ^b   Bielanska, Joanna ^a   Giese, Alf ^b   Mortensen, Lena Sünke ^a   Schulz Schaeffer, Walter J ^b   Stadelmann, Christine ^b   Brück, Wolfgang ^b   Pardo, Luis A ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Glioblastoma; Glioma initiating cells; Nestin; NG2; Patch clamp

Indexed keywords

GAP JUNCTION PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE RECEPTOR; NESTIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEOGLYCAN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL LINEAGE; ELECTROPHYSIOLOGY; GLIOMA CELL; GLIOMA INITIATING CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NERVE CELL; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM CURRENT; TUMOR CELL; ANIMAL; BRAIN TUMOR; CELL CULTURE; CHEMISTRY; GENETICS; GLIA; GLIOMA; IMMUNOPHENOTYPING; MEMBRANE POTENTIAL; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; TUMOR CELL LINE;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELLS, CULTURED; GLIOMA; HUMANS; IMMUNOPHENOTYPING; MEMBRANE POTENTIALS; MICE; NEUROGLIA; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 84877143550     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31828afdbd     Document Type: Article

References (72)

1. DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114-23
2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96
3. Cheng L, Wu Q, Guryanova OA, et al. Elevated invasive potential of glioblastoma stem cells. Biochem Biophys Res Commun 2011;406: 643-8
4. Facchino S, Abdouh M, Bernier G. Brain cancer stem cells: Current status on glioblastoma multiforme. Cancers (Basel) 2011;3:1777-97
5. Huse JT, Holland EC. Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 2010;10:319-31
6. Bachoo RM, Maher EA, Ligon KL, et al. Epidermal growth factor receptor and Ink4a/Arf: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 2002;1:269-77
7. Alcantara Llaguno S, Chen J, Kwon C-H, et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009;15:45-56
8. Liu C, Sage JC, Miller MR, et al. Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 2011;146:209-21
9. Persson AI, Petritsch C, Swartling FJ, et al. Non-stem cell origin for oligodendroglioma. Cancer Cell 2010;18:669-82
10. Chen J, McKay Renée M, Parada Luis F. Malignant glioma: Lessons from genomics, mouse models, and stem cells. Cell 2012;149:36-47
11. Visvader JE. Cells of origin in cancer. Nature 2011;469:314-22
12. Ehrmann J, Kolář Z, Mokrý J. Nestin as a diagnostic and prognostic marker: Immunohistochemical analysis of its expression in different tumours. J Clin Pathol 2005;58:222-23
13. Brat D, Prayson R, Ryken T, et al. Diagnosis of malignant glioma: Role of neuropathology. J Neuro-Oncol 2008;89:287-311
14. Chekenya M, Rooprai HK, Davies D, et al. The NG2 chondroitin sulfate proteoglycan: Role in malignant progression of human brain tumours. Int J Dev Neurosci 1999;17:421-35
15. Svendsen A, Verhoeff J, Immervoll H, et al. Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma. Acta Neuropathol 2011;122:495-510
16. Ignatova TN, Kukekov VG, Laywell ED, et al. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002;39:193-206
17. Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64:7011-21
18. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004;432:396-401
19. Gursel DB, Shin BJ, Burkhardt JK, et al. Glioblastoma stem-like cellsbiology and therapeutic implications. Cancers (Basel) 2011;3:2655-66
20. Vescovi AL, Galli R, Reynolds BA. Brain tumor stem cells. Nat Rev Cancer 2006;6:425
21. Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells - Perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 2006;66:9339-44
22. Al-Mayhani MTF, Grenfell R, Narita M, et al. NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature. Neuro-Oncol 2011;13:830-45
23. Ge W-P, Miyawaki A, Gage FH, et al. Local generation of glia is a major astrocyte source in postnatal cortex. Nature 2012;484:376-80
24. Tripathi RB, Clarke LE, Burzomato V, et al. Dorsally and ventrally derived oligodendrocytes have similar electrical properties but myelinate preferred tracts. J Neurosci 2011;31:6809-19
25. Lin S-C, Bergles DE. Physiological characteristics of NG2-expressing glial cells. J Neurocytol 2002;31:537-49
26. Wang DD, Krueger DD, Bordey A. Biophysical properties and ionic signature of neuronal progenitors of the postnatal subventricular zone in situ. J Neurophysiol 2003;90:2291-302
27. Schaarschmidt G, Wegner F, Schwarz SC, et al. Characterization of voltage-gated potassium channels in human neural progenitor cells. PLoS ONE 2009;4:e6168
28. Ge W-P, Zhou W, Luo Q, et al. Dividing glial cells maintain differentiated properties including complex morphology and functional synapses. Proc Natl Acad Sci USA 2009;106:328-33
29. Hamill OP, Marty A, Neher E, et al. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pfluegers Arch 1981;391:85-100
30. Bordey A, Sontheimer H. Electrophysiological properties of human astrocytic tumor cells in situ: Enigma of spiking glial cells. J Neurophysiol 1998;79:2782-93
31. Liu X, Chang Y, Reinhart PH, et al. Cloning and characterization of glioma BK, a novel BK channel isoform highly expressed in human glioma cells. J Neurosci 2002;22:1840-49
32. Ransom CB, Liu X, Sontheimer H. Current transients associated with BK channels in human glioma cells. J Membr Biol 2003;193:201-13
33. Ransom CB, Liu XJ, Sontheimer H. BK channels in human glioma cells have enhanced calcium sensitivity. Glia 2002;38:281-91
34. Ransom CB, Sontheimer H. BK channels in human glioma cells. J Neurophysiol 2001;85:790-803
35. Olsen ML, Sontheimer H. Mislocalization of Kir channels in malignant glia. Glia 2004;46:63-73
36. Olsen ML, Sontheimer H. Functional implications for Kir4.1 channels in glial biology: From K+ buffering to cell differentiation. J Neurochem 2008;107:589-601
37. Olsen ML, Schade S, Lyons SA, et al. Expression of voltage-gated chloride channels in human glioma cells. J Neurosci 2003;23:5572-82
38. Ishiuchi S, Tsuzuki K, Yoshida Y, et al. Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 2002;8:971-78
39. Ding X, He Z, Zhou K, et al. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. J Natl Cancer Inst 2010;102:1052-68
40. Joshi A, Parsons D, Velculescu V, et al. Sodium ion channel mutations in glioblastoma patients correlate with shorter survival. Molecular Cancer 2011;10:17
41. Louis DN, Ohgaki H, Wiestler OD, et al. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon, France: World Health Organization, 2007
42. Gómez-Varela D, Kohl T, Schmidt M, et al. Characterization of Eag1 channel lateral mobility in rat hippocampal cultures by single-particletracking with quantum dots. PLoS ONE 2010;5:e8858
43. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36
44. Pfaffl MW. A new mathematical model for relative quantification in real-time RTYPCR. Nucleic Acids Res 2001;29:e45
45. Fitzner D, Schneider A, Kippert A, et al. Myelin basic protein-dependent plasma membrane reorganization in the formation of myelin. EMBO J 2006;25:5037-48
46. Burg MA, Grako KA, Stallcup WB. Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells. J Cell Physiol 1998;177:299-312
47. Nishiyama A, Lin XH, Giese N, et al. Colocalization of NG2 proteoglycan and PDGF α-receptor on O2A progenitor cells in the developing rat brain. J Neurosci Res 1996;43:299-314
48. Mayer M, Bhakoo K, Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 1994;120:143-53
49. Lutz SE, Zhao Y, Gulinello M, et al. Deletion of Astrocyte Connexins 43 and 30 Leads to a Dysmyelinating Phenotype and Hippocampal CA1 Vacuolation. J Neurosci 2009;29:7743-52
50. Bergles DE, Roberts JDB, Somogyi P, et al. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 2000;405: 187-91
51. Schools GP, Zhou M, Kimelberg HK. Development of gap junctions in hippocampal astrocytes: Evidence that whole cell electrophysiological phenotype is an Intrinsic property of the individual cell. J Neurophysiol 2006;96:1383-92
52. Mueller J, Reyes-Haro D, Pivneva T, et al. The principal neurons of the medial nucleus of the trapezoid body and NG2+ glial cells receive coordinated excitatory synaptic input. J Gen Physiol 2009;134:115-27
53. Káradóttir R, Hamilton NB, Bakiri Y, et al. Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter. Nat Neurosci 2008;11:450-56
54. Schmidt K, Eulitz D, Veh RdW, et al. Heterogeneous expression of voltage-gated potassium channels of the shaker family (Kv1) in oligodendrocyte progenitors. Brain Res 1999;843:145-60
55. Paukert M, Bergles DE. Synaptic communication between neurons and NG2+ cells. Curr Opin Neurobiol 2006;16:515-21
56. McDougal DH, Hermann GE, Rogers RC. Vagal afferent stimulation activates astrocytes in the nucleus of the solitary tract via AMPA receptors: Evidence of an atypical neural-glial interaction in the brainstem. J Neurosci 2011;31:14037-45
57. de Groot J, Sontheimer H. Glutamate and the biology of gliomas. Glia 2011;59:1181-89
58. Fucile S, Miledi R, Eusebi F. Effects of cyclothiazide on GluR1/AMPA receptors. Proc Natl Acad Sci USA 2006;103:2943-47
59. Belachew S, Chittajallu R, Aguirre AA, et al. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol 2003;161:169-86
60. Komitova M, Zhu X, Serwanski DR, et al. NG2 cells are distinct from neurogenic cells in the postnatal mouse subventricular zone. J Comp Neurol 2009;512:702-16
61. Stallcup WB, Beasley L. Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan. J Neurosci 1987;7:2737-44
62. Ransom CB, Sontheimer H. Biophysical and pharmacological characterization of inwardly rectifying K+ currents in rat spinal cord astrocytes. J Neurophysiol 1995;73:333-46
63. Abdul M, Hoosein N. Expression and activity of potassium ion channels in human prostate cancer. Cancer letters 2002;186:99-105
64. Lai B, Mao XO, Xie L, et al. Electrophysiological properties of subventricular zone cells in adult mouse brain. Brain Res 2010;1340: 96-105
65. Claydon T, Kwan D, Fedida D, et al. Block by internal Mg2+ causes voltage-dependent inactivation of Kv1.5. Eur Biophys J 2006;36:23-34
66. Kukley M, Nishiyama A, Dietrich D. The fate of synaptic input to NG2 glial cells: Neurons specifically downregulate transmitter release onto differentiating oligodendroglial cells. J Neurosci 2010;30:8320-31
67. Biagiotti T, D'amico M, Marzi I, et al. Cell Renewing in Neuroblastoma: Electrophysiological and Immunocytochemical Characterization of Stem Cells and Derivatives. Stem Cells 2006;24:443-53
68. Sontheimer H. Astrocytes, as well as neurons, express a diversity of ion channels. Can J Physiol Pharmacol 1992;70 Suppl:S223-38
69. Chittajallu R, Aguirre A, Gallo V. NG2-positive cells in the mouse white and grey matter display distinct physiological properties. J Physiol 2004; 561:109-22
70. 2+ currents. Glia 1996;17:181-94
71. Sontheimer H. An unexpected role for ion channels in brain tumor metastasis. Exp Biol Med 2008;233:779-91
72. Schubert I, Kellner C, Stein C, et al. A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting. MAbs 2011;3:21-30 Biosciences